Why the study?
Does long term oral anticoagulant treatment reduce recurrent myocardial infarction, cerebrovascular events, and vascular events in hospital survivors of acute myocardial infarction?
Population
3,404 hospital survivors of acute myocardial infarction
Comparison
Long term oral anticoagulant treatment vs Placebo
Design
RCT, randomised, double blind
Authors
Loading...
Supports long-term anticoagulation post-MI to lower recurrent events; confirms consistent benefits across subgroups in this RCT.
Does long term oral anticoagulant treatment reduce recurrent myocardial infarction, cerebrovascular events, and vascular events in hospital survivors of acute myocardial infarction?
Long-term oral anticoagulant therapy provides consistent cardiovascular benefits in survivors of myocardial infarction across various prognostic subgroups.
Bergen et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: